Startup profile · funding coverage
ArcheHealth funding, valuation and investors
AI operational intelligence platform that shows hospitals the true patient-level cost of care.
Keep track of ArcheHealth
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$6.7M · June 2025
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$6.7M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Birmingham, AL
Investors in latest funding
Other: LRVHealth , Martin Ventures , Texas Health Resources
Overview
ArcheHealth builds an AI-infused platform that meshes clinical, financial, operational, and supply-chain data so hospitals can see actual costs of delivering care at a granular level — patients, items, and events — and act on labor, supply, and drug spend inefficiencies. CEO Ralph Keiser leads the Birmingham, AL company. In June 2025 ArcheHealth announced a $6.7M seed round funded by LRVHealth, Martin Ventures, and Texas Health Resources to scale the product and go-to-market.
Why ArcheHealth is interesting
Hospitals face margin pressure from labor and supply spend but still manage costs retrospectively. ArcheHealth’s bet is patient-event-item cost visibility — and it closed a $6.7M seed in June 2025 with health-system-aligned investors LRVHealth, Martin Ventures, and Texas Health Resources.
Product & use cases
ArcheHealth analyzes de-identified clinical, financial, and operational data from multiple hospital systems to surface process inefficiencies and true cost of care — shifting cost management from retrospective reports to actionable, proactive insight.
- Hospital CFOs and ops leaders hunting sustainable margin improvement
- Supply-chain and procure-to-pay teams benchmarking spend at item level
- Health systems wanting cost visibility tied to patient processes, not only GL summaries
Key facts
- Seed (June 2025): $6.7M from LRVHealth, Martin Ventures, and Texas Health Resources
- AI platform for patient-level hospital cost and operational intelligence
- HQ Birmingham, AL; CEO Ralph Keiser
- Targets labor, supply, and drug cost drivers without disrupting clinical workflows
Funding history (newest first)
Seed
2025-06 $6.7M- LRVHealth (participant)
- Martin Ventures (participant)
- Texas Health Resources (participant)
Competitive landscape
Edge: Purpose-built cost-of-care intelligence at patient-event-item granularity, backed by provider-network investors who sell into the same buyer persona.
-
Traditional cost accounting / decision-support suites incumbent
Often retrospective and finance-led; less real-time process insight.
-
Generic hospital analytics platforms adjacent
Broad BI; may lack deep multi-source cost-of-care modeling.
Industries
Related funding articles
Venture Capital Tracker pieces that cover ArcheHealth's financing or category context.
FAQs about ArcheHealth
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.